Exact Sciences (EXAS)
31.98
+0.18 +0.57%
NASDAQ
May 23, 14:39
Delayed 2m
USD
View All Key Stats
EXAS Key Stats
| Income Statement | |
| Revenue (TTM) | 132.90M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.47 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -154.68M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 64.89% |
| Profit Margin (Quarterly) | -72.26% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 3.556B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 25.42 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 11.49 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0154 |
| Free Cash Flow (Quarterly) | -36.38M |
| Return on Equity (TTM) | -50.06% |
View All EXAS News
EXAS News
-
WireHeadlineTime (ET)
-
Yahoo05/23 13:52
-
SA Breaking News05/23 13:04
-
Yahoo05/23 12:41
-
Yahoo05/23 09:55
-
PR Newswire05/22 12:24
-
PR Newswire05/19 16:05
-
Yahoo05/19 13:52
-
Yahoo05/16 17:40
-
Yahoo05/16 15:23
-
Yahoo05/16 11:19
View All Events
EXAS Events
| Date | Type | Description |
|---|---|---|
| 04/27/2017 09:00 CDT | Misc | Exact Sciences Corp First Quarter Earnings Conference Call in 2017 |
| 04/27/2017 | Earnings | Exact Sciences Corp First Quarter Earnings in 2017 Release |
| 02/21/2017 09:00 CDT | Misc | Exact Sciences Corp Fourth Quarter Earnings Conference Call in 2016 |
| 02/21/2017 | Earnings | Exact Sciences Corp Fourth Quarter Earnings in 2016 Release |
| 10/26/2016 09:00 CDT | Misc | Exact Sciences Corp Third Quarter Earnings Conference Call in 2016 |
| 10/26/2016 | Earnings | Exact Sciences Corp Third Quarter Earnings in 2016 Release |
| 07/26/2016 10:00 EDT | Misc | Exact Sciences Corp Second Quarter Earnings Conference Call in 2016 |
| 07/26/2016 | Earnings | Exact Sciences Corp Second Quarter Earnings in 2016 Release |
| 06/28/2016 | Misc | Exact Sciences Corp Annual General Meeting in 2015 |
EXAS Fundamentals
Income Statement View Statement
EXAS Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
EXAS One Page Reports
- One Page Report Download
EXAS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 31.98 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.exactsciences.com
- Investor Relations URL: http://investor.exactsciences.com/investor-relations/default.aspx
- HQ State/Province: Wisconsin
- Sector: Healthcare
- Industry: Diagnostics & Research
- Next Earnings Release: N/A
- Last Earnings Release: Apr. 27, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Exact Sciences Corp is a molecular diagnostics company currently focused on the early detection and prevention of colorectal cancer. It has developed a non‑invasive, patient friendly screening test called Cologuard(R).
EXAS Comparables
EditEXAS Excel Add-In Codes
- Name: =YCI("EXAS","name")
- Description: =YCI("EXAS","description")
- Sector: =YCI("EXAS","sector")
- Industry: =YCI("EXAS","industry")
- Est. Current Fiscal Year End: =YCI("EXAS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other EXAS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- EXAS Tweets Stocktwits
Advertisement